/NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICES/
CALGARY, AB, Dec. 31, 2020 /CNW/ - Mr. Clive J. Beddoe ("Mr. Beddoe") announces that he
has acquired beneficial ownership of 6,354,165 common shares of SQI
Diagnostics Inc. ("SQI") through the exercise of common share
purchase warrants of SQI ("Warrants") for aggregate consideration
of $1,333,333. Of the Warrants
exercised, 6,250,000 Warrants were exercised at a price of
$0.21 per common share, which
Warrants were issued pursuant to a private placement of units of
SQI on March 10, 2017, and 104,165
Warrants were exercised at a price of $0.20 per common share, which Warrants were
issued pursuant to a private placement of units of SQI on
December 20, 2017. Mr. Beddoe has
been a director of SQI since April 8, 2015.
Immediately prior to the transaction described herein, Mr.
Beddoe beneficially owned or exercised control or direction over
79,353,989 common shares, 48,244,303 Warrants and $440,000 principal amount of 10% secured
debentures due January 30, 2025 of
SQI, representing approximately 25.57% of the issued and
outstanding shares of SQI on a non-diluted basis and representing
approximately 35.58% of the issued and outstanding shares of SQI,
assuming the full exercise of all Warrants that Mr. Beddoe
beneficially owns or exercises control or direction over.
Immediately after the transaction described herein, Mr. Beddoe
beneficially owns or exercises control or direction over 85,708,154
common shares, 41,890,138 Warrants and $440,000 principal amount of 10% secured
debentures due January 30, 2025 of
SQI, representing approximately 26.02% of the issued and
outstanding shares of SQI on a non-diluted basis and representing
approximately 34.37% of the issued and outstanding shares of SQI,
assuming the full exercise of all Warrants that Mr. Beddoe
beneficially owns or exercises control or direction over.
The securities described herein were acquired for investment
purposes. Mr. Beddoe may increase or decrease his investment,
directly or indirectly, in securities of SQI from time to time,
depending on market conditions or any other relevant factors.
A copy of the report relating to this acquisition may be found
on SQI's profile at www.SEDAR.com or may be obtained from Mr.
Ryan Ogrodniczuk at 403-266-6203 or
at Mr. Beddoe's address c/o Hanover Investments Corporation Ltd.,
396-11th Avenue SW, Suite 1320, Calgary, Alberta T2R 0C5. SQI's head
office is located at 36 Meteor Drive, Toronto, Ontario M9W 1A4.
SOURCE SQI Diagnostics Inc.